Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.

World journal of gastroenterology - 28 May 2007

Lu Hai-Ying, Zhuang Li-Wei, Yu Yan-Yan, Ivan Hadad, Si Chong-Wen, Zeng Zheng, Li Jun, Hou Dong-Ming, Chen Xin-Yue, Han Zhong-Hou, Chen Yong

Abstract excerpt

AIM: To evaluate the effect of antiviral agents on intrahepatic HBV DNA in HBeAg-positive chronic hepatitis B patients. METHODS: Seventy-one patients received treatment with lamivudine, interferon alpha (IFN-alpha 2b) or sequential therapy with lamivudine-IFN-alpha 2b for 48 wk. All subjects were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis B, Chronic
Share to Hepatitis B e Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Lamivudine

Share to Predictive Value of Tests

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 17569128
DOI: 10.3748/wjg.v13.i20.2878
PMCID: PMC4395644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17569128-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.PMID 17569128Read ↗

Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.Semantic proximity Read ↗

[Clinical significance of intrahepatic HCV RNA level in chronic HCV infection].Semantic proximity Read ↗

The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.Semantic proximity Read ↗

Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B.Semantic proximity Read ↗

An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients.Semantic proximity Read ↗

[Relationship between hepatitis B virus YMDD mutation and serum viral DNA loadings].Semantic proximity Read ↗

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.Semantic proximity Read ↗

Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.